LAVAL, QUEBEC--(Marketwire - April 21, 2010) - Warnex Inc. (TSX: WNX) invites all interested parties to attend its Annual Meeting of Shareholders.
Date: Tuesday, April 27, 2010 Time: 11:00 am Location: Sheraton Laval, Salon Duvernay 2440 Autoroute des Laurentides Laval, Quebec
In addition to the formal business described in the Management Information Circular, Mark Busgang, President and CEO of Warnex, will present an update on corporate activities.
About Warnex
Warnex (www.warnex.ca) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex Analytical Services provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex Bioanalytical Services specializes in bioequivalence and bioavailability studies for clinical trials. Warnex Medical Laboratories provides specialized testing for the healthcare industry as well as pharmaceutical and central laboratory services. Warnex PRO-DNA Services offers DNA identification tests for paternity, maternity and other family relationships, as well as for immigration and forensic testing purposes. Warnex has three facilities located in Laval and Blainville, Quebec, and Thunder Bay, Ontario.
Contacts:
Warnex Inc.
Mark J. Busgang
President & CEO
450-663-6724 x 310
mbusgang@warnex.ca
Warnex Inc.
Catherine Sartoros
Communications Specialist
450-663-6724 x 277
csartoros@warnex.ca
www.warnex.ca